PeptideDB

Crenulatin

CAS No.: 63026-02-8

Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Crenulatin has dual- direction effects on apoptosis of cerebral microvascular endothelial cells, inhibitive effect in 25 mg/L and stimulative effect in 100 mg/L group, respectively; the mechanism is related to the alterations of Fas/Bcl-2 expression and caspase-3 activity.
In vitro The following terminal concentrations of Crenulatin were used in the study: 25 mg/L and 100 mg/L. Apoptosis of mouse cerebral microvascular endothelial cells (bEnd. 3 cell line) was evaluated by flow cytometer, immunocytochemical assay (Fas, Bcl - 2) and Western blotting (caspase - 3) after culture for 24 h. Compared with control group, apoptosis of bEnd. 3 cells in 25 mg/L group was significantly inhibited ( P
molecular weight 248.275
Molecular formula C11H20O6
CAS 63026-02-8
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Dual- direction effect of crenulatin on apoptosis of cerebral microvascular endothelial cells and it's mechanismChinese Journal of Pathophysiology, 2005, 21(11):2086-2090.